Protective axis of the renin-angiotensin system in the brain

Clinical Science

Volumn 127, Issue 5, 2014, Pages 295-306

  Gironacci, Mariela M ^a   Cerniello, Flavia M ^a   Longo Carbajosa, Nadia A ^a   Goldstein, Jorge ^b   Cerrato, Bruno D ^a  

^a Instituto de Quimica y Fisicoquimica Biologicas Buenos Aires   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Angiotensin (1 7); Angiotensin converting enzyme 2 (ACE2); Baroreflex; Hypertension; Mas receptor; Noradrenergic neurotransmission; Renin angiotensin system(RAS)

Indexed keywords

4 AMINOBUTYRIC ACID; ALDOSTERONE; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; BRADYKININ; DOPAMINE; NEUROTRANSMITTER; NORADRENALIN; RENIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN I (1-7); DIPEPTIDYL CARBOXYPEPTIDASE; G PROTEIN COUPLED RECEPTOR; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTO-ONCOGENE PROTEINS C-MAS-1;

4 AMINOBUTYRIC ACID RELEASE; ADRENERGIC SYSTEM; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN REGION; CARDIOVASCULAR FUNCTION; DOPAMINE RELEASE; DOWN REGULATION; GENE EXPRESSION; HEART RATE VARIABILITY; HORMONE RELEASE; HUMAN; HYPERTENSION; NEUROMODULATION; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; ANIMAL; BLOOD PRESSURE; BRAIN; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; RAT; SECRETION (PROCESS);

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; BAROREFLEX; BLOOD PRESSURE; BRAIN; NEUROTRANSMITTER AGENTS; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PROTO-ONCOGENE PROTEINS; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, G-PROTEIN-COUPLED; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 84899787539     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130450     Document Type: Article

References (90)

1. McKinley, M. J., Albiston, A. L., Allen, A. M., Mathai, M. L., May, C. N., McAllen, R. M., Oldfield, B. J., Mendelsohn, F. A. O. and Chai, S. Y. (2003) The brain renin-angiotensin system: location and physiological roles. Int. J. Biochem. Cell Biol. 35, 901-918 CrossRef PubMed
2. Marc, Y., and Llorens-Cortes, C. (2011) The role of the brain renin-angiotensin system in hypertension: implications for new treatment. Prog. Neurobiol. 95, 89-103 CrossRef PubMed
3. Grobe, J. L., Xu, D., and Sigmund, C. D. (2008) An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy. Physiology 23, 187-293 CrossRef PubMed
4. Kumar, R., Thomas, C. M., Yong, Q. C., Chen, W., and Baker, K. M. (2012) The intracrine renin-angiotensin system. Clin. Sci. 123, 273-284 CrossRef PubMed
5. Welches, W. R., Santos, R. A., Chappell, M. C., Brosnihan, K. B., Greene, L. J., and Ferrario, C. M. (1991) Evidence that prolyl endopeptidase participates in the processing of brain angiotensin. J. Hypertens. 9, 631-638 CrossRef PubMed
6. Yamamoto, K., Chappell, M. C., Brosnihan, K. B., and Ferrario, C. M. (1992) In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension 19, 692-696 CrossRef PubMed
7. Karamyan, V. T., and Speth, R. C. (2007) Enzymatic pathways of the brain renin-angiotensin system: unsolved problems, and continuing challenges. Regul. Pept. 143, 15-27 CrossRef PubMed
8. Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R. et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87, E1-E9 CrossRef PubMed
9. Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., and Turner, A. J. (2000) A human homolog of angiotensin-converting enzyme. Cloning, and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275, 33238-33243 CrossRef PubMed
10. Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F. et al. (2002) Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 277, 14838-14843 CrossRef PubMed
11. Doobay, M. F., Talman, L. S., Obr, T. D., Tian, X., Davisson, R. L., and Lazartigues, E. (2007) Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R373-R381 CrossRef PubMed
12. Gallagher, P. E., Chappell, M. C., Ferrario, C. M., and Tallant, E. A. (2006) Distinct roles for ANG II, and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. Am. J. Physiol. Cell Physiol. 290, C420-C426 CrossRef PubMed
13. Block, C. H., Santos, R. A., Brosnihan, K. B., and Ferrario, C. M. (1988) Immunocytochemical localization of angiotensin-(1-7) in the rat forebrain. Peptides 9, 1395-1401 CrossRef PubMed
14. Lopez Verrilli, M. A., Pirola, C. J., Pascual, M. M., Dominici, F. P., Turyn, D., and Gironacci, M. M. (2009) Angiotensin-(1-7) through AT2 receptors mediates tyrosine hydroxylase degradation via the ubiquitin-proteasome pathway. J. Neurochem. 109, 326-335 CrossRef PubMed
15. Arnold, A. C., Sakima, A., Kasper, S. O., Vinsant, S., Garcia-Espinosa, M. A., and Diz, D. I. (2012) The brain renin-angiotensin system, and cardiovascular responses to stress: insights from transgenic rats with low brain angiotensinogen. J. Appl. Physiol. 113, 1929-1936 CrossRef PubMed
16. Chappell, M. C., Brosnihan, K. B., Diz, D. I., and Ferrario, C. M. (1989) Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides. J. Biol. Chem. 264, 16518-16523 PubMed
17. Pereira, M. G., Souza, L. L., Becari, C., Duarte, D. A., Camacho, F. R., Oliveira, J. A., Gomes, M. D., Oliveira, E. B., Salgado, M. C., Garcia-Cairasco, N., and Costa-Neto, C. M. (2013) Angiotensin II-independent angiotensin-(1-7) formation in rat hippocampus: involvement of thimet oligopeptidase. Hypertension 62, 879-885 CrossRef PubMed
18. Gouveia, T. L., Frangiotti, M. I., de Brito, J. M., de Castro Neto, E. F., Sakata, M. M., Febba, A. C., Casarini, D. E., Amado, D., Cavalheiro, E. A., Almeida, S. S. et al. (2012) The levels of renin-angiotensin related components are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy. Neurochem. Int. 61, 54-62 CrossRef PubMed
19. Santos, R. A., Simoes e Silva, A. C., Maric, C., Silva, D. M., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V., Lopes, M. T., Bader, M. et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U.S.A. 100, 8258-8263 CrossRef PubMed
20. Becker, L. K., Etelvino, G. M., Walther, T., Santos, R. A., and Campagnole-Santos, M. J. (2007) Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain. Am. J. Physiol. Heart Circ. Physiol. 293, H1416-H1424 CrossRef PubMed
21. Mecca, A. P., Regenhardt, R. W., O'Connor, T. E., Joseph, J. P., Raizada, M. K., Katovich, M. J., and Sumners, C. (2011) Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke. Exp. Physiol. 96, 1084-1096 PubMed
22. Lopez Verrilli, M. A., Rodriguez Fermepin, M., Longo Carbajosa, N., Landa, S., Cerrato, B. D., Garcia, S., Fernandez, B. E., and Gironacci, M. M. (2012) Angiotensin-(1-7) through Mas receptor up-regulates neuronal norepinephrine transporter via Akt, and Erk1/2-dependent pathways. J. Neurochem. 120, 46-55 CrossRef PubMed
23. Freund, M., Walther, T., and von Bohlen und Halbach, O. (2012) Immunohistochemical localization of the angiotensin-(1-7) receptor Mas in the murine forebrain. Cell Tissue Res. 348, 29-35 CrossRef PubMed
24. Campagnole-Santos, M. J., Diz, D. I., Santos, R. A., Khosla, M. C., Brosnihan, K. B., and Ferrario, C. M. (1989) Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats. Am. J. Physiol. 257, H324-
25. Dampney, R. A. (1994) Functional organization of central pathways regulating the cardiovascular system. Physiol. Rev. 74, 323-364 PubMed
26. Dampney, R. A., Horiuchi, J., Killinger, S., Sheriff, M. J., Tan, P. S., and McDowall, L. M. (2005) Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions. Clin. Exp. Pharmacol. Physiol. 32, 419-425 CrossRef PubMed
27. Couto, A. S., Baltatu, O., Santos, R. A., Ganten, D., Bader, M., and Campagnole-Santos, M. J. (2002) Differential effects of angiotensin II, and angiotensin-(1-7) at the nucleus tractus solitarii of transgenic rats with low brain angiotensinogen. J. Hypertens. 20, 919-925 CrossRef PubMed
28. Thrasher, T. N. (2004) Baroreceptors, and the long-term control of blood pressure. Exp. Physiol. 89, 331-335 CrossRef PubMed
29. Gironacci, M. M., Longo Carbajosa, N., Goldstein, J., and Cerrato, B. D. (2013) Neuromodulatory role of angiotensin-(1-7) in the central nervous system. Clin. Sci. 125, 57-65 CrossRef PubMed
30. Oliveira, D. R., Santos, R. A., Santos, G. F., Khosla, M., and Campagnole-Santos, M. J. (1996) Changes in the baroreflex control of heart rate produced by central infusion of selective angiotensin antagonists in hypertensive rats. Hypertension 27, 1284-1290 CrossRef PubMed
31. Arnold, A. C., Sakima, A., Ganten, D., Ferrario, C. M., and Diz, D. I. (2008) Modulation of reflex function by endogenous angiotensins in older transgenic rats with low glial angiotensinogen. Hypertension 51, 1326-1331 CrossRef PubMed
32. Diz, D. I., Garcia-Espinosa, M. A., Gallagher, P. E., Ganten, D., Ferrario, C. M., and Averill, D. B. (2008) Angiotensin-(1-7), and baroreflex function in nucleus tractus solitarii of (mRen2)27 transgenic rats. J. Cardiovasc. Pharmacol. 51, 542-548 CrossRef PubMed
33. Nautiyal, M., Shaltout, H. A., de Lima, D. C., do Nascimento, K., Chappell, M. C., and Diz, D. I. (2012) Central angiotensin-(1-7) improves vagal function independent of blood pressure in hypertensive (mRen2) 27 rats. Hypertension 60, 1257-1265 CrossRef PubMed
34. Garcia-Espinosa, M. A., Shaltout, H. A., Gallagher, P. E., Chappell, M. C., and Diz, D. I. (2012) In vivo expression of angiotensin-(1-7) lowers blood pressure, and improves baroreflex function in transgenic (mRen2)27 rats. J. Cardiovasc. Pharmacol. 60, 150-157 CrossRef PubMed
35. Isa, K., Arnold, A. C., Westwood, B. M., Chappell, M. C., and Diz, D. I. (2011) Angiotensin-converting enzyme inhibition, but not AT1 receptor blockade, in the solitary tract nucleus improves baroreflex sensitivity in anesthetized transgenic hypertensive (mRen2)27 rats. Hypertens. Res. 34, 1257-1262 CrossRef PubMed
36. de Moura, M. M., dos Santos, R. A., Campagnole-Santos, M. J., Todiras, M., Bader, M., Alenina, N., and Haibara, A. S. (2010) Altered cardiovascular reflexes responses in conscious angiotensin-(1-7) receptor Mas-knockout mice. Peptides 31, 1934-1939 CrossRef PubMed
37. Shaltout, H. A., Rose, J. C., Chappell, M. C., and Diz, D. I. (2012) Angiotensin-(1-7) deficiency, and baroreflex impairment precede the antenatal Betamethasone exposure-induced elevation in blood pressure. Hypertension 59, 453-458 CrossRef PubMed
38. Marshall, A. C., Shaltout, H. A., Nautiyal, M., Rose, J. C., Chappell, M. C., and Diz, D. I. (2013) Fetal betamethasone exposure attenuates angiotensin-(1-7)-Mas receptor expression in the dorsal medulla of adult sheep. Peptides 44, 25-31 CrossRef PubMed
39. Alzamora, A. C., Santos, R. A., and Campagnole-Santos, M. J. (2006) Baroreflex modulation by angiotensins at the rat rostral, and caudal ventrolateral medulla. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R1027-R1034 CrossRef PubMed
40. Ferreira, P. M., Alzamora, A. C., Santos, R. A., and Campagnole-Santos, M. J. (2008) Hemodynamic effect produced by microinjection of angiotensins at the caudal ventrolateral medulla of spontaneously hypertensive rats. Neuroscience 151, 1208-1216 CrossRef PubMed
41. Alzamora, A. C., Santos, R. A., and Campagnole-Santos, M. J. (2002) Hypotensive effect of ANG II, and ANG-(1-7) at the caudal ventrolateral medulla involves different mechanisms. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R1187-R1195 PubMed
42. Hirooka, Y., Potts, P. D., and Dampney, R. A. (1997) Role of angiotensin II receptor subtypes in mediating the sympathoexcitatory effects of exogenous, and endogenous angiotensin peptides in the rostral ventrolateral medulla of the rabbit. Brain Res. 772, 107-114 CrossRef PubMed
43. Lin, K. S., Chan, J. Y., and Chan, S. H. (1997) Involvement of AT2 receptors at NRVL in tonic baroreflex suppression by endogenous angiotensins. Am. J. Physiol. 272, H2204-H2210 PubMed
44. Fontes, M. A., Martins Pinge, M. C., Naves, V., Campagnole-Santos, M. J., Lopes, O. U., Khosla, M. C., and Santos, R. A. (1997) Cardiovascular effects produced by microinjection of angiotensins, and angiotensin antagonists into the ventrolateral medulla of freely moving rats. Brain Res. 750, 305-310 CrossRef PubMed
45. Lima, D. X., Fontes, M. A., Oliveira, R. C., Campagnole-Santos, M. J., Khosla, M. C., and Santos, R. A. (1996) Pressor action of angiotensin I at the ventrolateral medulla: effect of selective angiotensinblockade. Immunopharmacology 33,305-307 CrossRef PubMed
46. Fontes, M. A., Silva, L. C., Campagnole-Santos, M. J., Khosla, M. C., Guertzenstein, P. G., and Santos, R. A. (1994) Evidence that angiotensin-(1-7) plays a role in the central control of blood pressure at the ventro-lateral medulla acting through specific receptors. Brain Res. 665, 175-180 CrossRef PubMed
47. Sun, H. J., Li, P., Chen, W. W., Xiong, X. Q., and Han, Y. (2012) Angiotensin II, and angiotensin-(1-7) in paraventricular nucleus modulate cardiac sympathetic afferent reflex in renovascular hypertensive rats. PLoS ONE 7,e52557 CrossRef PubMed
48. da Silva, A. Q., Fontes, M. A., and Kanagy, N. L. (2011) Chronic infusion of angiotensin receptor antagonists in the hypothalamic paraventricular nucleus prevents hypertension in a rat model of sleep apnea. Brain Res. 1368, 231-238 CrossRef PubMed
49. Wyss, J. M., and Carlson, S. H. (2001) The role of the nervous system in hypertension. Curr. Hypert. Rep. 3, 255-262 CrossRef
50. Gelband, C. H., Sumners, C., and Raizada, M. K. (1997) Angiotensin receptors, and norepinephrine neuromodulation: implications of functional coupling. Regul. Pept. 72, 139-145 CrossRef PubMed
51. Stragier, B., Hristova, I., Sarre, S., Ebinger, G., and Michotte, Y. (2005) In vivo characterization of the angiotensin-(1-7)-induced dopamine, and gamma-aminobutyric acid release in the striatum of the rat. Eur. J. Neurosci. 22, 658-664 CrossRef PubMed
52. Lazaroni, T. L., Raslan, A. C., Fontes, W. R., de Oliveira, M. L., Bader, M., Alenina, N., Moraes, M. F., Dos Santos, R. A., and Pereira, G. S. (2012) Angiotensin-(1-7)/Mas axis integrity is required for the expression of object recognition memory. Neurobiol. Learn. Mem. 97, 113-123 CrossRef PubMed
53. Bild, W., and Ciobica, A. (2013) Angiotensin-(1-7) central administration induces anxiolytic-like effects in elevated plus maze, and decreased oxidative stress in the amygdala. J. Affect. Disord. 145, 165-171 CrossRef PubMed
54. Regenhardt, R. W., Desland, F., Mecca, A. P., Pioquinto, D. J., Afzal, A., Mocco, J., and Sumners, C. (2013) Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke. Neuropharmacology 71, 154-163 CrossRef PubMed
55. Jiang, T., Gao, L., Guo, J., Lu, J., Wang, Y., and Zhang, Y. (2012) Suppressing inflammation by inhibiting the NF-?B pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia. Br. J. Pharmacol. 167, 1520-1532 CrossRef PubMed
56. Zhang, Y., Lu, J., Shi, J., Lin, X., Dong, J., Zhang, S., Liu, Y., and Tong, Q. (2008) Central administration of angiotensin-(1-7) stimulates nitric oxide release, and upregulates the endothelial nitric oxide synthase expression following focal cerebral ischemia/reperfusion in rats. Neuropeptides 42, 593-600 CrossRef PubMed
57. Regenhardt, R. W., Mecca, A. P., Desland, F., Ritucci-Chinni, P. F., Ludin, J. A., Greenstein, D., Banuelos, C., Bizon, J. L., Reinhard, M. K., and Sumners, C. (2014) Centrally administered angiotensin-(1-7) increases the survival of stroke-prone spontaneously hypertensive rats. Exp Physiol. 99, 442-453 CrossRef PubMed
58. Lu, J., Jiang, T., Wu, L., Gao, L., Wang, Y., Zhou, F., Zhang, S., and Zhang, Y. (2013) The expression of angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas receptor axis are upregulated after acute cerebral ischemic stroke in rats. Neuropeptides 47, 289-295 CrossRef PubMed
59. Jiang, T., Gao, L., Shi, J., Lu, J., Wang, Y., and Zhang, Y. (2013) Angiotensin-(1-7) modulates renin-angiotensin system associated with reducing oxidative stress, and attenuating neuronal apoptosis in the brain of hypertensive rats. Pharmacol. Res. 67, 84-89 CrossRef PubMed
60. Jiang, T., Gao, L., Zhu, X. C., Yu, J. T., Shi, J. Q., Tan, M. S., Lu, J., Tan, L., and Zhang, Y. D. (2013) Angiotensin-(1-7) inhibits autophagy in the brain of spontaneously hypertensive rats. Pharmacol. Res. 71, 61-68 CrossRef PubMed
61. Freund, M., Walther, T., and von Bohlen Und Halbach, O. (2013) Effects of the angiotensin-(1-7) receptor Mas on cell proliferation, and on the population of doublecortin positive cells within the dentate gyrus, and the piriform cortex. Eur. Neuropsychopharmacol. 24, 302-308 CrossRef PubMed
62. Albrecht, D. (2007) Angiotensin-(1-7)-induced plasticity changes in the lateral amygdala are mediated by COX-2, and NO. Learn. Mem. 14, 177-184 CrossRef PubMed
63. Xing, J., Kong, J., Lu, J., and Li, J. (2012) Angiotensin-(1-7) inhibits neuronal activity of dorsolateral periaqueductal gray via a nitric oxide pathway. Neurosci. Lett. 522, 156-161 CrossRef PubMed
64. Gironacci, M. M., Valera, M. S., Yujnovsky, I., and Peña, C. (2004) Angiotensin-(1-7) inhibitory mechanism of norepinephrine release in hypertensive rats. Hypertension 44, 783-787 CrossRef PubMed
65. Yang, R. F., Yin, J. X., Li, Y. L., Zimmerman, M. C., and Schultz, H. D. (2011) Angiotensin-(1-7) increases neuronal potassium current via a nitric oxide-dependent mechanism. Am. J. Physiol. Cell. Physiol. 300, C58-C64 CrossRef PubMed
66. Li, P., Sun, H. J., Cui, B. P., Zhou, Y. B., and Han, Y. (2013) Angiotensin-(1-7) in the rostral ventrolateral medulla modulates enhanced cardiac sympathetic afferent reflex, and sympathetic activation in renovascular hypertensive rats. Hypertension 61, 820-827 CrossRef PubMed
67. Han, Y., Sun, H. J., Li, P., Gao, Q., Zhou, Y. B., Zhang, F., Gao, X. Y., and Zhu, G. Q. (2012) Angiotensin-(1-7) in paraventricular nucleus modulates sympathetic activity, and cardiac sympathetic afferent reflex in renovascular hypertensive rats. PLoS ONE 7, e48966 CrossRef PubMed
68. Li, P., Zhang, F., Zhou, Y. B., Cui, B. P., and Han, Y. (2012) Superoxide anions modulate the effects of angiotensin-(1-7) in the rostral ventrolateral medulla on cardiac sympathetic afferent reflex, and sympathetic activity in rats. Neuroscience 223, 388-398 CrossRef PubMed
69. Cheng, W. H., Lu, P. J., Hsiao, M., Hsiao, C. H., Ho, W. Y., Cheng, P. W., Lin, C. T., Hong, L. Z., and Tseng, C. J. (2012) Renin activates PI3K-Akt-eNOS signalling through the angiotensin AT1, and Mas receptors to modulate central blood pressure control in the nucleus tractus solitarii. Br. J. Pharmacol. 166, 2024-2035 CrossRef PubMed
70. Clarke, N. E., and Turner, A. J. (2012) Angiotensin-converting enzyme 2: the first decade. Int. J. Hypertens. 2012, 307-315 CrossRef
71. Lambert, D. W., Clarke, N. E., Hooper, N. M., and Turner, A. J. (2008) Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2), and inhibits shedding of its ectodomain. FEBS Lett. 582, 385-390 CrossRef PubMed
72. Lai, Z. W., Lew, R. A., Yarski, M. A., Mu, F. T.,, Andrews, R. K., and Smith, A. I. (2009) The identification of a calmodulin-binding domain within the cytoplasmic tail of angiotensin-converting enzyme-2. Endocrinology 150, 2376-2381 CrossRef PubMed
73. Lambert, D. W., Yarski, M., Warner, F. J., Thornhill, P., Parkin, E. T., Smith, A. I., Hooper, N. M., and Turner, A. J. (2005) Tumor necrosis factor-a convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme- 2 (ACE2). J. Biol. Chem. 280,30113-30119 CrossRef PubMed
74. Xia H., Sriramula, S., Chhabra, K. H., and Lazartigues, E. (2013) Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension. Circ. Res. 113, 1087-1096 CrossRef PubMed
75. Lautner, R. Q., Villela, D. C., Fraga-Silva, R. A., Silva, N., Verano-Braga, T., Costa-Fraga, F., Jankowski, J., Jankowski, V., Sousa, F., Alzamora, A. et al. (2013) Discovery, and characterization of alamandine: a novel component of the renin-angiotensin system. Circ. Res. 112, 1104-1111 CrossRef PubMed
76. Carey, R. M. (2013) Newly discovered components, and actions of the renin-angiotensin system. Hypertension 62, 818-822 CrossRef PubMed
77. Kazemi-Bajestani, S. M., Patel, V. B., Wang, W., and Oudit, G. Y. (2012) Targeting the ACE2, and apelin pathways are novel therapies for heart failure: opportunities, and challenges. Cardiol. Res. Pract. 2012,823193 PubMed
78. Falcao-Pires I. and Leite-Moreira, A. F. (2005) Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance, and potential use as a therapeutic target. Rev. Port. Cardiol. 24, 1263-1276 PubMed
79. Dai, L., Smith, P. M., Kuksis, M., and Ferguson, A. V. (2013) Apelin acts in the subfornical organ to influence neuronal excitability, and cardiovascular function. J. Physiol. 591, 3421-3432 CrossRef PubMed
80. Khaksari, M., Aboutaleb, N., Nasirinezhad, F., Vakili, A., and Madjd, Z. (2012) Apelin-13 protects the brain against ischemic reperfusion injury, and cerebral edema in a transient model of focal cerebral ischemia. J. Mol. Neurosci. 48, 201-208 CrossRef PubMed
81. Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y. et al. (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417, 822-828 CrossRef PubMed
82. Yamazato, M., Yamazato, Y., Sun, C., Diez-Freire, C., and Raizada, M. K. (2007) Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats. Hypertension 49, 926-931 CrossRef PubMed
83. Yamazato, M., Ferreira, A. J., Yamazato, Y., Diez-Freire, C., Yuan, L., Gillies, R., and Raizada, M. K. (2011) Gene transfer of angiotensin-converting enzyme 2 in the nucleus tractus solitarius improves baroreceptor heart rate reflex in spontaneously hypertensive rats. J. Renin Angiotensin Aldosterone Syst. 12, 456-461 CrossRef PubMed
84. Feng, Y., Xia, H., Cai, Y., Halabi, C. M., Becker, L. K., Santos, R. A., Speth, R. C., Sigmund, C. D., and Lazartigues, E. (2010) Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension.Circ. Res.,106,373-382 CrossRef PubMed
85. Kar, S., Gao, L., and Zucker, I. H. (2010) Exercise training normalizes ACE, and
86. Xiao, L., Gao, L., Lazartigues, E., and Zucker, I. H. (2011) Brain-selective overexpression of angiotensin-converting enzyme 2 attenuates sympathetic nerve activity, and enhances baroreflex function in chronic heart failure. Hypertension 58, 1057-1065 CrossRef PubMed
87. Feng, Y., Yue, X., Xia, H., Bindom, S. M., Hickman, P. J., Filipeanu, C. M., Wu, G., and Lazartigues, E. (2008) Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor, and drinking responses, and is associated with angiotensin II type 1 receptor downregulation. Circ. Res. 102, 729-736 CrossRef PubMed
88. Sriramula, S., Cardinale, J. P., Lazartigues, E., and Francis, J. (2011).ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension.Cardiovasc. Res.,92,401-408 CrossRef PubMed
89. Xia, H., Suda, S., Bindom, S., Feng, Y., Gurley, S. B., Seth, D., Navar, L. G., and Lazartigues, E. (2011) ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function. PLoS ONE 6, e22682 CrossRef PubMed
90. Diz, D. I., Garcia-Espinosa, M. A., Gegick, S., Tommasi, E. N., Ferrario, C. M., Ann Tallant, E., Chappell, M. C., and Gallagher, P. E. (2008) Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats. Exp. Physiol. 93, 694-700 CrossRef PubMed